SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-063059
Filing Date
2022-12-30
Accepted
2022-12-30 21:12:30
Documents
2
Period of Report
2022-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11207
2 POA DOCUMENT poa.txt EX-24 3649
  Complete submission text file 0001209191-22-063059.txt   16265
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Castelli Jeff (Reporting) CIK: 0001569225 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33497 | Film No.: 221503088